<code id='AADF3E86DE'></code><style id='AADF3E86DE'></style>
      • <acronym id='AADF3E86DE'></acronym>
      <center id='AADF3E86DE'><center id='AADF3E86DE'><tfoot id='AADF3E86DE'></tfoot></center><abbr id='AADF3E86DE'><dir id='AADF3E86DE'><tfoot id='AADF3E86DE'></tfoot><noframes id='AADF3E86DE'>
      • <optgroup id='AADF3E86DE'><strike id='AADF3E86DE'><sup id='AADF3E86DE'></sup></strike><code id='AADF3E86DE'></code></optgroup>
        5. <b id='AADF3E86DE'><label id='AADF3E86DE'><select id='AADF3E86DE'><dt id='AADF3E86DE'><span id='AADF3E86DE'></span></dt></select></label></b><u id='AADF3E86DE'></u>
          <i id='AADF3E86DE'><strike id='AADF3E86DE'><tt id='AADF3E86DE'><pre id='AADF3E86DE'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / comprehensive / hotspot      
           
     
           
      
          hotspot 
           
      
           
      
           
       2025-09-06 10:04:22 
   
      
           
      
           
                        
          hotspot  
          
                                   
                 
                                      author：focus   
                                        
                                      
                                      Page View：9
                                  
                                    
          
                                   
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. 																									Jim Mone/AP
          Home health and hospice chain Amedisys has chosen a new corporate owner.
          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.
          advertisement
          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.
          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!					
          GET STARTED													Log In											
                      
                              
          
                                 Previous article：

                                
                                          Readout Newsletter: Biotech news, including Moderna's Covid vaccine
                                
                            
          Next article：  
                                      
                                          Drug repurposing or repositioning? The language matters
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles